PL1758569T3 - Sole guanylohydrazonowe, kompozycje, sposoby ich wytwarzania i stosowania - Google Patents

Sole guanylohydrazonowe, kompozycje, sposoby ich wytwarzania i stosowania

Info

Publication number
PL1758569T3
PL1758569T3 PL05763891T PL05763891T PL1758569T3 PL 1758569 T3 PL1758569 T3 PL 1758569T3 PL 05763891 T PL05763891 T PL 05763891T PL 05763891 T PL05763891 T PL 05763891T PL 1758569 T3 PL1758569 T3 PL 1758569T3
Authority
PL
Poland
Prior art keywords
compositions
processes
making
methods
guanylhydrazone salts
Prior art date
Application number
PL05763891T
Other languages
English (en)
Inventor
Thais M Sielecki-Dzurdz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PL1758569T3 publication Critical patent/PL1758569T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PL05763891T 2004-06-25 2005-06-27 Sole guanylohydrazonowe, kompozycje, sposoby ich wytwarzania i stosowania PL1758569T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58253204P 2004-06-25 2004-06-25
US60199204P 2004-08-17 2004-08-17
US11/165,255 US7244765B2 (en) 2004-06-25 2005-06-24 Guanylhydrazone salts, compositions, processes of making and methods of using
EP05763891.8A EP1758569B1 (en) 2004-06-25 2005-06-27 Guanylhydrazone salts, compositions, processes of making and methods of using
PCT/US2005/022626 WO2006004613A2 (en) 2004-06-25 2005-06-27 Guanylhydrazone salts, compositions, processes of making and methods of using

Publications (1)

Publication Number Publication Date
PL1758569T3 true PL1758569T3 (pl) 2013-10-31

Family

ID=35600290

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05763891T PL1758569T3 (pl) 2004-06-25 2005-06-27 Sole guanylohydrazonowe, kompozycje, sposoby ich wytwarzania i stosowania

Country Status (12)

Country Link
US (3) US7244765B2 (pl)
EP (2) EP2540703B1 (pl)
JP (2) JP5086072B2 (pl)
CN (1) CN1968686B (pl)
AU (1) AU2005260126B2 (pl)
BR (1) BRPI0511819A (pl)
CA (1) CA2566648C (pl)
DK (1) DK1758569T3 (pl)
ES (1) ES2424356T3 (pl)
PL (1) PL1758569T3 (pl)
PT (1) PT1758569E (pl)
WO (1) WO2006004613A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
PT1778265E (pt) * 2004-08-17 2013-08-05 Ferring Bv Compostos, composições e métodos de fabrico e utilização de guanilhidrazona
US20110201686A1 (en) * 2006-06-23 2011-08-18 Yousef Al-Abed Inhibitors of ASS and Synuclein Aggregation
WO2009054994A2 (en) * 2007-10-23 2009-04-30 President And Fellows Of Harvard College Sirt-3 related methods and compositions for mimicking exercise
AU2009298948B2 (en) * 2008-09-19 2013-06-20 Ferring B.V. Guanylhydrazones for treatment of postoperative intestinal inflammation

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704397A (en) 1980-03-11 1987-11-03 Warner-Lambert Company Pharmaceutical salts of 4-(9-acridinyl-amino) methanesulfon-m-anisidide
US4321253A (en) 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
DK147640C (da) 1982-06-11 1985-05-06 Dumex Ltd As Fremgangsmaade til fremstilling af nitroimidazol-derivater
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US4791196A (en) 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5028625A (en) 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
US6008255A (en) * 1994-01-21 1999-12-28 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US5567592A (en) 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
US5993858A (en) 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
WO1998002186A1 (en) 1996-07-11 1998-01-22 Farmarc Nederland B.V. Inclusion complex containing indole selective serotonin agonist
ES2339306T3 (es) * 1996-11-15 2010-05-18 Cytokine Pharmasciences, Inc. Guanilhidrazonas utiles en el tratamiento de las enfermedades asociadas con la activacion de las celulas t.
US6319894B1 (en) * 1997-01-08 2001-11-20 The Picower Institute For Medical Research Complexes and combinations of fetuin with therapeutic agents
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2760190B1 (fr) 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
US6277406B1 (en) * 1997-10-08 2001-08-21 Fuisz Technologies Ltd. Easily processed tablet compositions
DE60022692T2 (de) 1999-07-01 2006-06-22 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
ES2250363T3 (es) * 2000-02-02 2006-04-16 Dorian Bevec Guanilhidrazonas aromaticas farmaceuticamente activas.
WO2002000613A2 (en) * 2000-06-27 2002-01-03 Axxima Pharmaceuticals Ag Inhibitors of hepatitis b virus infection
JP5412023B2 (ja) 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
WO2002058699A1 (en) 2001-01-25 2002-08-01 Bristol-Myers Squibb Company Pharmaceutical forms of epothilones for oral administration
CA2445860A1 (en) 2001-04-30 2002-11-07 Shire Laboratories Inc. Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
US20030198669A1 (en) 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
AU2002336746A1 (en) * 2001-09-21 2003-04-01 Message Pharmaceuticals, Inc. Inhibitors of rnase p proteins as antibacterial compounds
US6689777B2 (en) 2001-10-23 2004-02-10 Kenneth S. Warren Institute Anti-malarial compounds, compositions and methods
EP1451174B1 (en) 2001-11-29 2010-08-18 Schering Corporation Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
CA2467555A1 (en) 2001-11-29 2003-08-14 Schering Corporation Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
JP2005522457A (ja) * 2002-02-26 2005-07-28 ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート 脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
GB0207104D0 (en) 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist
EP1389480A1 (en) * 2002-08-14 2004-02-18 Mondobiotech Interferon SA Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
US7244765B2 (en) 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
US7795314B2 (en) * 2005-06-01 2010-09-14 Cytokine Pharmasciences, Inc. Protective role of semapimod in necrotizing enterocolitis

Also Published As

Publication number Publication date
US20060014833A1 (en) 2006-01-19
WO2006004613A2 (en) 2006-01-12
JP2008504288A (ja) 2008-02-14
CA2566648A1 (en) 2006-01-12
US8497306B2 (en) 2013-07-30
AU2005260126B2 (en) 2012-04-19
EP2540703A1 (en) 2013-01-02
US20080262090A1 (en) 2008-10-23
JP5086072B2 (ja) 2012-11-28
EP1758569A2 (en) 2007-03-07
DK1758569T3 (da) 2013-07-01
BRPI0511819A (pt) 2007-12-26
EP1758569B1 (en) 2013-05-08
EP1758569A4 (en) 2010-01-20
JP5576416B2 (ja) 2014-08-20
AU2005260126A1 (en) 2006-01-12
WO2006004613A3 (en) 2006-05-26
US7244765B2 (en) 2007-07-17
PT1758569E (pt) 2013-08-23
JP2012121905A (ja) 2012-06-28
US8034840B2 (en) 2011-10-11
CN1968686A (zh) 2007-05-23
CA2566648C (en) 2013-04-02
CN1968686B (zh) 2013-01-16
EP2540703B1 (en) 2015-05-27
US20080146670A1 (en) 2008-06-19
ES2424356T3 (es) 2013-10-01

Similar Documents

Publication Publication Date Title
IL180897A0 (en) Method of producing a composition, composition and its use
ZA200700351B (en) Compounds, compositions and methods
IL182765A0 (en) Pyridazine compounds, compositions and methods
IL178860A0 (en) Certain chemical entities, compositions, and methods
IL191137A0 (en) Polycation-polyanion complexes, compositions and methods of use thereof
IL180742A0 (en) Method of manufacture
PT1928840E (pt) 1h-pirazole-4-carboxamidas, a sua preparação e a sua utilização a título de inibidores de 11-betahidroxiesteróide desidrogenase
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
IL183136A0 (en) Modified alginates, methods of production and use
PL1758569T3 (pl) Sole guanylohydrazonowe, kompozycje, sposoby ich wytwarzania i stosowania
ZA200804814B (en) Mortar composition, method of preparation thereof and use thereof
PL1778265T3 (pl) Związki guanylohydrazonowe, kompozycje, sposoby wytwarzania i stosowania
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
GB0417036D0 (en) Compounds, compositions and devices
GB0516245D0 (en) Process, composition and compound
IL182970A0 (en) Compositions and processes for preparing 13-deoxy-anthracyclines
GB0520930D0 (en) Composition and method of use
GB0403696D0 (en) Process and composition
GB0506496D0 (en) Compound, composition and use
ZA200700704B (en) Compositions containing nicorandil, preparation method and use
GB2444005B (en) Compound, composition and use
ZA200805284B (en) Tetrafluorotoluene compound, method for producing same and use thereof
PL370009A1 (pl) Sposób wytwarzania S-(-)-1,2,3,4-tetrahydro-2-naftolu
PL366493A1 (pl) Sposób wytwarzania S-(-)-1,2,3,4-tetrahydro-2-naftolu
GB0520690D0 (en) Compound, composition and use